Skip to main content

RA

ETF
Financials
Asset Management

Performance overview

RA Price
Price Chart

Forward-looking statistics

Beta
0.34
Risk
10.60%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investingĀ in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities (collectively, Real Asset Companies and Issuers). The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.

Fund info

Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investingĀ in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities (collectively, Real Asset Companies and Issuers). The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.

Investing methodUnknown
DiversifiedNo
Expense ratio—
Asset classUnknown

Top holdings

Other100.00%

Sector exposure

Other100.00%

Country exposure

Other100.00%

Company info

SectorFinancials
IndustryAsset Management
AUM$708.6M

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)$1.18
Dividend per share$1.42
Revenue per share—
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$3M
Put-call ratioN/A

Macro factor sensitivity

Growth+0.5
Credit+1.6
Liquidity+0.1
Inflation-0.1
Commodities-0.8
Interest Rates-1.8

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend day—

News

Morgan Stanley's Ben Swinburne: Here's how AI could change how we consume entertainment

Ben Swinburne, Morgan Stanley head of U.S. media research, joins CNBC's 'Squawk on the Street' to discuss which media companies are poised to benefit most from AI, how the technology will change how consumers interact with entertainment, and more.

CNBC Television (July 11, 2025)
RARE, MREO Fall as Osteogenesis Study Likely to Continue Till Year End

Ultragenyx Pharmaceutical and Mereo BioPharma shares tumble as investors await key phase III UX143 osteogenesis data now set for release at year-end.

Zacks Investment Research (July 10, 2025)
Ultragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?

Ultragenyx (RARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Investment Research (July 10, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free